Pfizer Tukysa — Revenues: increased by 2.5% to $122.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19.6%, from $102.00M to $122.00M.
pfe_segment_tukysa_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $18.00M | $106.00M | $121.00M | $124.00M | $129.00M | $102.00M | $132.00M | $110.00M | $119.00M | $122.00M |
| QoQ Change | — | — | — | — | — | — | — | — | — | — | — | +488.9% | +14.2% | +2.5% | +4.0% | -20.9% | +29.4% | -16.7% | +8.2% | +2.5% |
| YoY Change | — | — | — | — | — | — | — | — | — | — | — | — | — | — | +616.7% | -3.8% | +9.1% | -11.3% | -7.8% | +19.6% |